Coonrad-Morrey total elbow arthroplasty for patients with rheumatoid arthritis: 54 prostheses reviewed at 7 years' average follow-up (maximum, 16 years) by Pham, Thuy Trang et al.
  
 
 
 
 
 
Open Archive Toulouse Archive Ouverte (OATAO) 
OATAO is an open access repository that collects the work of some Toulouse 
researchers and makes it freely available over the web where possible. 
 
 
This is an author's version published in: https://oatao.univ-toulouse.fr/23097 
 
 
 
 
Official URL : https://doi.org/10.1016/j.jse.2017.11.007 
 
To cite this version : 
 
 
 
 
 
 
 
 
 
 
 
Any correspondence concerning this service should be sent to the repository administrator: 
tech-oatao@listes-diff.inp-toulouse.fr 
 
 
Pham, Thuy Trang and Delclaux, Stéphanie and Huguet, Sandrine and Wargny, Matthieu 
and Bonnevialle, Nicolas  and Mansat, Pierre  Coonrad-Morrey total elbow arthroplasty for 
patients with rheumatoid arthritis: 54 prostheses reviewed at 7 years' average follow-up 
(maximum, 16 years). (2018) Journal of Shoulder and Elbow Surgery, 27 (3). 398-403. ISSN 
1058-2746 
OATAO 
Open Archive Toulouse Archive Ouverte 
Coonrad-Morrey total elbow arthroplasty for
patients with rheumatoid arthritis: 54 prostheses
reviewed at 7 years’ average follow-up (maximum,
16 years)
Thuy Trang Pham, MDa,*, Stéphanie Delclaux, MDb, Sandrine Huguet, MDc,
Matthieu Wargny, MDd, Nicolas Bonnevialle, MD, PhDb, Pierre Mansat, MD, PhDb
aService de Chirurgie Orthopédique et Traumatologique Pédiatrique, Hôpital des Enfants, Toulouse, France
bService de Chirurgie Orthopédique et Traumatologique, Hôpital Pierre Paul Riquet, CHU Toulouse, Toulouse, France
cService de Chirurgie de la Main et de Chirurgie Plastique et Reconstructrice de l’Appareil Locomoteur, Centre Chirurgical
Emile Gallé, Nancy, France
dInserm UMR 1087/CNRS UMR 6291, Nantes, France
Background: Total elbow arthroplasty is a therapeutic option for severe rheumatoid arthritis. We hypoth-
esized that the semiconstrained characteristics of the Coonrad-Morrey prosthesis do not compromise the
survival rate of the implant in a rheumatoid elbow.
Methods: Between 1997 and 2012, there were 54 Coonrad-Morrey total elbow prostheses performed for
rheumatoid arthritis in 46 patients. Minimum follow-up was 2 years. There were 35 women and 11 men
with a mean age of 60 years (29-83 years). According to the Mayo classification for rheumatoid elbow,
there were 30 type IIIA, 21 type IIIB, and 3 type IV. The surgical procedure was the same for all pa-
tients. Survivorship was assessed with use of the Kaplan-Meier method, with revision surgery as the end
point.
Results: The survival rate was 97% (95% confidence interval, 83.6-99.6) at 5 years and 85% (95% con-
fidence interval, 68.3-93.7) at 10 years. At an average of 7 years of follow-up (2-16 years), the mean Mayo
Elbow Performance Score was 91 points (55-100 points), and the shortened version of the Disabilities of
the Arm, Shoulder, and Hand score was 34 points (0-75 points). There was a significant improvement in
Mayo Elbow Performance Score and in all range of motion at latest follow-up in comparison to preop-
erative values (P < .0001). Radiolucencies were observed in 6 cases around the humeral component and
in 6 cases around the ulnar component. Bushing wear was observed in 16 cases (29%). There were 14
complications (26%). Revisions were performed in 6 of them (11%).
Conclusion: The Coonrad-Morrey prosthesis provides satisfactory results with follow-up. The rate of com-
plications remains high even if the rate of implant revision stayed low.
Institutional Review Board approval was not required for this study. All pa-
tients were informed about the use of their personal data for this study, and
all accepted.
*Reprint requests: Thuy Trang Pham, MD, Service de Chirurgie
Orthopédique et Traumatologique Pédiatrique, Hôpital des Enfants, CHU
Toulouse, 31059 Toulouse cedex 9, France.
E-mail address: francethuytrang@yahoo.fr (T.T. Pham).
Level of e-ndence: Level IV; Case Series; Treatment Study 
Keywords: Semiconstrained; total elbow arthroplasty; Coonrad-Morrey total elbow prosthesis; rheumatoid 
arthritis; survival rate; linked prosthesis 
Rheumatoid arthritis (RA) affects roughly 1 %-2% of the 
general population; it affects the elbow in 20%-65% of pa-
tients and is isolated to the elbow in 5% of cases.19 Despite 
progress in the medical treatment of RA, notably in 
biotherapies, total elbow arthroplasty remains a therapeutic 
option in severe cases after failure of medical treatment. 
The problems to consider are often pain during joint move-
ment, loss of mobility, and elbow instability in the case of 
advanced osseous destruction or ligament insufficiency.2•6•17•24 
The elbow prosthesis used should thus eliminate pain, allow 
recuperation of a functional elbow range of motion, and ensure 
stability of the elbow. A semiconstrained prosthesis fulfills 
these criteria.9•10 However, this type of prosthesis presents the 
potential risk of complications, notably due to mechanical 
failure but also due to loosening in the long term as well as 
infection in patients who are often immunosuppressed. Few 
studies report the long-term results in this context.4·w,,s,2o The 
objective of this study was to evaluate the long-term out-
cornes and survival of the Coonrad-Morrey semiconstrained 
prosthesis in RA. It was hypothesized that the prosthesis would 
be viable in the long term, with a survival rate of 80% at 10 
years. The principal judgment criterion was the prosthesis sur-
vival curve at 5 and 10 years. Secondary judgment criteria 
included clinical results according to the Mayo Elbow Per-
formance Score (MEPS), radiography results, and complication 
and revision rates. 
Materials and methods 
Patients 
This was a retrospective, monocentric study of a cohort prospec-
tively observed since 1997. Inclusion criteria included ail patients 
presenting with elbow RA for which a Coonrad-Morrey prosthesis 
was used as first-line treatment between 1997 and 2012 and re-
viewed within a minimum of 2 years. Exclusion criteria included 
patients who had Coonrad-Morrey total elbow arthroplasty for a con-
dition other than RA, for the revision of a previous prosthesis, or 
with a follow-up period of <2 years. During this period, 151 Coonrad-
Morrey prostheses were administered in our department, 80 of which 
were for elbow RA. Sixty-six had a follow-up of at least 2 years, 6 
of which were admitted for distal humerus fracture. Six prostheses 
were placed for the revision of another prosthesis. Overall, 46 pa-
tients (54 elbows) were included, with an average follow-up of 7 
years (2-16 years). Surgery was bilateral for 8 cases. Patients in-
cluded 35 women and 11 men, with an average age of 60 years (29-
83 years) at the time of surgery. Accorcling to the Mayo classification 
for rheumatoid elbow, 30 cases were type IIIA, 21 cases were type 
IIIB, and 3 cases were type IV. 
Evaluation criteria 
Clinical evaluation was carried out preoperatively and at final 
follow-up by MEPS.14 Joint mobility was measured using agoni-
ometer. Strength was analyzed by an evaluation against resistance 
and against gravity in flexion and extension, with elbow flexed 
90°, and compared with the opposite elbow. Strength was consid-
ered normal when it was between 80% and 100% of the opposite 
elbow. Loss of strength was considered moderate when strength 
was observed as 50%-80% of the opposite elbow and severe if 
<50%. The shortened version of the Disabilities of the Arro, Shoul-
der, and Hand (QuickDASH) score was also evaluated at final 
follow-up.1•13 
Radiographie analysis was carried out at final follow-up by stan-
dard radiography of the elbow in anterior-posterior and lateral views. 
Loosening was evaluated between O and 4 accorcling to Morrey et al. 15 
Wear of the polyethylene bushings in the prosthetic hinge was judged 
by anterior-posterior radiography of the elbow; an absence of bushing 
wear was considered when the angle of the ulnar implant in rela-
tion to the humerai implant was <3.5°, wear was considered partial 
for an angle of up to 5°, and total wear was considered for an angle 
>5o.8 
Surgical technique 
Surgical intervention was similar for aJJ patients. Patients were placed 
in a supine position with the forearm on the abdomen. The Bryan-
Morrey approach was used in ail cases. Ulnar nerve transposition 
was systematically carried out. Bone preparation and implant po-
sitioning were performed accorcling to Morrey's recommendations.14 
The implant was fixed with cernent according to recommenda-
tions by Faber et al3: after washing and drying of the canais, a low-
viscosity cernent with antibiotics was injected with an adapted cernent 
gun. The triceps were then reinserted by transosseous sutures ac-
cording to the description by Morrey.14 Postoperatively, the elbow 
was immobilized in extension using an anterior splint for 48 hours, 
then a simple sling was left for 3 weeks. No rehabilitation was pre-
scribed, and the patient was allowed to move the elbow accorcling 
to the level of pain. Lifting was limited to 5 kg for a single effort 
or 1 kg for repeated efforts. 
Statistical analysis 
Statistical analysis was by x2 test for qualitative variables and by 
Student test for quantitative variables. A clifference was estimated 
to be statistically significant when the P value was < .05. The sur-
vival rate was analyzed accorcling to the Kaplan-Meier method, with 
95% confidence interval, with revision due to any cause consid-
ered an end point. Calculations were performed with the statistical 
analysis program R (version 2.14.1). 
Results
Principal judgment criterion
The survival rate was calculated, with the revision of the
implant, irrespective of the cause, considered an end point.
The survival rate, analyzed according to the Kaplan-Meier
method, was 97% at 5 years (95% confidence interval, 83.6-
99.6) and 85% at 10 years (95% confidence interval, 68.3-
93.7) (Fig. 1).
Secondary judgment criteria
Clinical results
At an average follow-up of 7 years (2-16 years), the mean
MEPS score was 91 points (range, 55-100 points) and the
QuickDASH score was 34 points (range, 0-75 points). Pa-
tients had no or minimal pain in 92.5% of cases. All elbows
were stable. There was a significant improvement in MEPS
score and in all range of motion at latest follow-up in com-
parison to preoperative values (P = .0001) (Table I). Strength
in flexion was normal in 44 cases (81%). There was a slight
diminution of strength in 9 cases and severe diminution in 1
case. On the other hand, a loss of extension strength was ob-
served in 19 cases (35%), 15 of which showed moderate loss
and 4 of which showed severe loss. At latest follow-up, results
according to MEPS were excellent in 38 cases (70%), good
in 11 cases (20%), moderate in 3 cases (6%), and poor in 2
cases (4%).
Radiography results
At latest follow-up, periprosthetic humeral lucent lines were
found in 6 cases (11%), including 1 type 1, 1 type 2, 1 type
3, and 3 type 4. Periprosthetic ulnar lucent lines were observed
in 6 cases, 2 type 1 and 4 type 4. Implant loosening was ob-
served for 3 humeral and 4 ulnar implants (Fig. 2). Bushing
wear was observed in 16 cases (29%); it was moderate for
11 cases and severe for 5 cases.
Complications and revisions
There were 14 complications (26%). Weakness of the triceps
was noted in 4 cases. Ulnar nerve lesion involving paresthe-
sia without sensory-motor deficiency was observed in 3 cases,
but all cases resolved spontaneously. Seven complications
(13%) required surgical revision. Deep infection was found
in 3 cases (5.5%), for which 2 required surgery for resection
Figure 1 Kaplan-Meier survivorship curve with revision surgery for all causes as the end point, with 95% confidence interval (CI).
Table I Preoperative and latest follow-up functional results
Preoperative Latest follow-up P
Mean ± standard
deviation
Mean ± standard
deviation
Flexion 121 ± 14 136 ± 12 <10−4
Extension 42 ± 18 23 ± 16 <10−4
Arc of flexion-
extension
78 ± 27 110 ± 25 <10−4
Pronation 53 ± 24 69 ± 14 <10−4
Supination 47 ± 28 70 ± 16 <10−4
Arc of pronation-
supination
100 ± 49 138 ± 27 <10−4
MEPS score 37 ± 11 91 ± 12 <10−4
Pain 5 ± 7 40 ± 9 <10−4
Mobility 15 ± 4 18 ± 2 <10−4
Stability 5 ± 3 10 ± 1 <10−4
Function 12 ± 5 22 ± 4 <10−4
MEPS, Mayo Elbow Performance Score.
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arthroplasty and 1 for bipolar prosthesis replacement. Among
3 cases of aseptic implant loosening, 2 cases were symptom-
atic, including 1 ulnar component loosening that required ulnar
implant replacement and 1 bipolar implant loosening that re-
quired bipolar prosthetic replacement. One asymptomatic
humeral loosening did not require surgical revision. One frac-
ture of the ulnar implant was observed and required
replacement of the ulnar implant (Fig. 3), and a periprosthetic
fracture of the ulna was treated orthopedically. None of the
patients with bushing wear (29%) required exchange of
bushings.
Discussion
The results of this study confirm our hypothesis that the
semiconstrained Coonrad-Morrey prosthesis is viable in the
long term, with a survival rate of 80% at 10 years. Few studies
have evaluated the long-term results of the Coonrad-Morrey
prosthesis in RA. Indeed, results from the longest follow-up
study, published by Gill and Morrey,4 of 78 prostheses carried
out in the context of RA showed a survival rate of 94.4% at
5 years and 92.4% at 10 years. This study was recently updated
by Sanchez-Sotelo et al,20 who reviewed 461 primary total
elbow arthroplasties using the Coonrad-Morrey prosthesis per-
formed in 387 patients with RA with 10 years of median
follow-up (range, 2-30 years). The rate of survivorship free
of implant revision or removal for any reason was 92% at
10 years, 83% at 15 years, and 68% at 20 years. The survi-
vorship at 20 years was 88% with revision due to aseptic
loosening as the end point and 89% with isolated bushing ex-
change as the end point. The survival rate in our study, 97%
at 5 years and 85% at 10 years, was lower than that re-
ported by the prosthesis designer’s study but comparable to
survival rates reported in the literature. A study derived from
the Finnish Arthroplasty Register,21 which evaluated the dif-
ferent types of total elbow prosthesis in RA, found no
difference between survival rates for unconstrained prostheses,
Figure 2 Bipolar loosening at 6 years after initial surgery.
Figure 3 (A) Elbow radiographs, anteroposterior and lateral views of the ulnar component fracture. (B) Postoperative elbow radiographs,
anteroposterior and lateral views after replacement of the ulnar implant. A diaphyseal corticotomy was performed to remove the broken ulnar
component.
Souter-Strathclyde (n = 912) and i.B.P/Kudo (n = 218), and
semiconstrained prostheses, Coonrad-Morrey (n = 164) and
NESimplavit/Norway (n = 63). The overall survival rate for
the implants at 10 years was 83% (95% confidence interval,
81-86). A comparative study by Little et al10 found the sur-
vival rate at 5 years to be 85% for the Souter-Strathclyde
prosthesis, 93% for the Kudo prosthesis, and 90% for the
Coonrad-Morrey prosthesis, with no significant differences.
The functional results for these 3 prostheses were equiva-
lent, with the Coonrad-Morrey semiconstrained prosthesis
showing an advantage for preventing the risk of dislocation
without increasing the rate of loosening. Prasad and Dent18
evaluated the Souter-Strathclyde prosthesis (n = 44; mean
follow-up of 108 months) and the Coonrad-Morrey prosthe-
sis (n = 55; mean follow-up of 60 months) in RA and found
the survival rate at 5 years to be 92.9% and 100%, respec-
tively. The Scottish Arthroplasty Project,7 which assessed the
outcome of 1146 total elbow prostheses, 79% of which were
implemented because of an inflammatory arthropathy, found
that a better survival rate was associated with implants that
were carried out by experienced surgeons who performed >10
implants per year.
The primary indication for total elbow arthroplasty in severe
RA of the elbow is pain and, to a lesser extent, loss of mo-
bility and functional limitation. In the study of Gill and
Morrey,4 reviewing 78 Coonrad-Morrey prostheses per-
formed for RA of the elbow, 46 with an average follow-up
of 136 months (120-184 months) showed satisfactory results
with a MEPS score of 90 points in 91% of cases at latest
follow-up evaluation. Furthermore, 98% of elbows pre-
sented with minimal or no pain, and all cases regained normal
functional elbow motion and elbow stability. In the study of
Sanchez-Sotelo et al,20 the MEPS was 90 points, and pain was
graded mild or absent in 87% of the elbows. In our study, at
mean follow-up of 7 years, the mean MEPS was 91 points
and the QuickDASH score was 34 points. Patients had minimal
or no pain in 92.5% of cases, and all elbows were stable.
Mansat et al11 evaluated 78 Coonrad-Morrey prostheses that
were performed for different conditions and found that at a
mean follow-up of 5 years, patients treated for inflammato-
ry arthritis had better functional results than those treated for
traumatic conditions.
Despite an improvement in pain level and function, the
complication and revision rates remained high compared with
those of shoulder, hip, and knee prostheses. In our study, the
complication rate was 26% and the revision rate was 11%.
The rate of infection (5.5%) was higher than the rates of other
arthroplasties but comparable to previously published infec-
tion rates for total elbow prostheses.10,20,22,23 Infection rate may
appear higher in patients suffering RA because of a modifi-
cation of the immune response as a result of medical treatment.
Bushing wear at the position of the hinge was found in 29%
of cases. None of these patients required revision surgery for
isolated replacement of the bushing. Lee et al8 found a greater
risk of bushing wear in younger patients with post-traumatic
arthritis or with severe initial deformation. Pham et al16 reported
1 case of iterative revision surgery for polyethylene bushing
wear without implant loosening, requiring a custom-designed
locking hinge to stabilize the implants. Finally, a study by
Mansat et al,12 evaluating 15 Coonrad-Morrey prostheses at
>10-year follow-up, found a correlation between bushing wear
and the follow-up. Lucent lines were observed around the
humeral component in 6 cases and around the ulnar compo-
nent in 6 cases, requiring a revision mainly at the ulna.
Loosening was found mainly around the polymethyl meth-
acrylate precoated ulnar component that is no longer used.
Hildebrand et al5 had already pointed out this complication
in their series. It seems that with the titanium plasma-spray
coating ulnar component used nowadays, the incidence of
lucent lines decreases.20,22
The limitations of our study were its retrospective and
noncomparative nature. Not all patients had the same follow-
up, which could influence the survival analysis. However, our
study represented a continuous series carried out in a single
center, using a single type of semiconstrained prosthesis and
an identical surgical technique in all patients. The strength
of our study was the long follow-up (mean follow-up of 7
years and maximum follow-up of 16 years), which allows us
to evaluate the long-term reliability of this implant in RA.
Conclusion
The Coonrad-Morrey semiconstrained prosthesis in RA
gave satisfactory results in the long term, with a survival
rate of 85% at 10 years of follow-up. The clinical results
are satisfactory in 90% of cases with the recuperation of
a pain-free, functional, and stable elbow. The complica-
tion rate is not negligible with the follow-up, and
complications include predominantly infections, bushing
wear, and implant loosening, particularly around the ulnar
component.
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